#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	17818	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2235	793.8	0	.	n	.	0	C451T	SNP	451	451	C	699	699	T	1101	T,G	992,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	17818	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2235	793.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1432	1432	C	1000	C,T,G	899,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	33586	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3549	943.7	0	.	n	.	0	T695C	SNP	695	695	T	1006	1006	C	1068	C,T	970,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	33586	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3549	943.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2282	2282	C	1038	C	937	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	33586	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3549	943.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2356	2356	A	1073	A	983	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	33586	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3549	943.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	2908	2908	C	1031	C,A	931,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	33586	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3549	943.7	0	HET	.	.	.	A1638G	.	1638	1638	A	1949	1949	A	1087	A,G	776,204	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	33586	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3549	943.7	0	HET	.	.	.	G2616A	.	2616	2616	G	2927	2927	G	1045	G,A	735,205	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2548	folP	855	855	100.0	folP.l15.c30.ctg.1	1470	172.5	1	SNP	p	R229S	1	.	.	685	687	AGC	958	960	AGC	256;257;257	A;G;C,T	235;237;233,1	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6640	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3424	193.4	1	SNP	p	S91F	1	.	.	271	273	TTC	595	597	TTC	224;226;222	T;T;C	204;205;201	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6640	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3424	193.4	1	SNP	p	D95G	1	.	.	283	285	GGC	607	609	GGC	222;221;223	G;G,T;C	196;195,1;200	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6640	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3424	193.4	1	SNP	p	G95N	0	.	.	283	285	GGC	607	609	GGC	222;221;223	G;G,T;C	196;195,1;200	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	2016	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1197	167.0	1	SNP	p	G45D	0	.	.	133	135	GGC	403	405	GGC	223;225;225	G;G;C	206;208;207	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	962	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	923	103.4	0	.	n	.	0	A197.	DEL	197	197	A	605	605	A	228	A	202	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6370	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2730	231.6	1	SNP	p	D86N	0	.	.	256	258	GAC	446	448	GAC	268;266;267	G;A;C	246;243;246	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6370	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2730	231.6	1	SNP	p	S87R	1	.	.	259	261	CGT	449	451	CGT	269;266;266	C;G;T	249;243;243	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6370	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2730	231.6	1	SNP	p	R87I	0	.	.	259	261	CGT	449	451	CGT	269;266;266	C;G;T	249;243;243	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6370	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2730	231.6	1	SNP	p	R87W	0	.	.	259	261	CGT	449	451	CGT	269;266;266	C;G;T	249;243;243	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6370	parC	2304	2304	100.0	parC.l15.c17.ctg.1	2730	231.6	1	SNP	p	S88P	0	.	.	262	264	TCC	452	454	TCC	265;265;262	T,A;C;C	245,1;245;243	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5448	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2489	217.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1499	1501	GGC	263;260;262	G;G;C	237;234;234	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4976	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2407	205.9	1	SNP	p	A311V	0	.	.	931	933	GCC	1312	1314	GCC	279;282;280	G;C,A;C	251;253,1;252	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4976	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2407	205.9	1	SNP	p	I312M	1	.	.	934	936	ATG	1315	1317	ATG	282;277;283	A;T;G	254;251;256	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4976	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2407	205.9	1	SNP	p	T316P	0	.	.	946	948	ACC	1327	1329	ACC	263;262;262	A;C;C	240;237;238	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4976	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2407	205.9	1	SNP	p	V316T	1	.	.	946	948	ACC	1327	1329	ACC	263;262;262	A;C;C	240;237;238	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4976	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2407	205.9	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1828	1830	ACC	258;258;256	A;C,T;C	227;227,1;227	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4976	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2407	205.9	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1882	1884	GCG	239;236;235	G;C;G	215;212;211	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4976	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2407	205.9	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1882	1884	GCG	239;236;235	G;C;G	215;212;211	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4976	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2407	205.9	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2005	2007	GGT	220;217;218	G;G;T	190;190;188	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4976	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2407	205.9	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2014	2016	AGC	209;205;202	A,G;G;C	180,1;176;174	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4976	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2407	205.9	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2032	2034	CCG	180;186;190	C,G;C,G;G,T	134,9;141,2;146,2	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	7128	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3230	220.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1650	1652	CCG	257;257;256	C;C;G	220;235;223	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2554	porA	1146	1146	99.91	porA.l15.c17.ctg.1	1688	150.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	559	559	C	183	C	158	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3420	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1641	207.7	0	.	p	.	0	G210R	NONSYN	628	630	GGA	942	944	AGA	274;272;272	A;G;A	256;255;255	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3420	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1641	207.7	0	.	p	.	0	S217G	NONSYN	649	651	AGT	963	965	GGT	284;286;286	G;G;T	264;266;268	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3420	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1641	207.7	1	SNP	p	G120K	1	.	.	358	360	AAG	672	674	AAG	312;313;315	A;A;G	272;276;273	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3420	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1641	207.7	1	SNP	p	A121N	1	.	.	361	363	AAC	675	677	AAC	319;316;313	A;A;C	282;277;276	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3420	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1641	207.7	1	SNP	p	N121D	0	.	.	361	363	AAC	675	677	AAC	319;316;313	A;A;C	282;277;276	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	12990	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4742	273.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1420	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	920	153.2	1	SNP	p	V57M	1	.	.	169	171	ATG	460	462	ATG	291;295;290	A;T;G	271;275;269	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
